Cargando…

Network pharmacology and molecular docking reveal potential mechanism of esculetin in the treatment of ulcerative colitis

Ulcerative colitis (UC) is a chronic inflammatory bowel disease of the colonic mucosa. Esculetin is a type of natural coumarin that has many pharmacological activities such as antioxidant, anticancer, anti-inflammatory, etc. A previous study showed that esculetin improved intestinal inflammation and...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Ting, Cai, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637478/
https://www.ncbi.nlm.nih.gov/pubmed/37960728
http://dx.doi.org/10.1097/MD.0000000000035852
_version_ 1785146506728177664
author Cai, Ting
Cai, Bin
author_facet Cai, Ting
Cai, Bin
author_sort Cai, Ting
collection PubMed
description Ulcerative colitis (UC) is a chronic inflammatory bowel disease of the colonic mucosa. Esculetin is a type of natural coumarin that has many pharmacological activities such as antioxidant, anticancer, anti-inflammatory, etc. A previous study showed that esculetin improved intestinal inflammation and reduced serum proinflammatory cytokines in UC. The present study aimed to utilize network pharmacology and molecular docking to explore the potential mechanism of esculetin against UC. The potential gene targets of esculetin were predicted through SwissTargetPrediction and Super-PRED web servers. UC-related genes were obtained from DisGeNet, OMIM, and GeneCards databases. The overlap between gene targets of esculetin and UC-related genes were identified as the potential targets of esculetin against UC. The interaction between these overlapping genes was analyzed by the STRING database and the core genes were identified by Cytoscape platform. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis of the core genes were then performed. And the results of these analyses were further confirmed through molecular docking. A total of 50 overlapping genes were identified as the potential action targets of esculetin against UC. Among them, 10 genes (AKT1, STAT1, CCND1, SRC, PTGS2, EGFR, NFKB1, ESR1, MMP9, SERPINE1) were finally identified as the core genes. The Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis results showed that the top signaling pathway associated with the core genes of esculetin against UC was the prolactin (PRL) signaling pathway. Molecular docking results showed that esculetin has a strong binding affinity to the core genes, as well as PRL and prolactin receptor. This study suggests that esculetin may have a crucial impact on UC through the PRL signaling pathway and provides insights into the potential mechanism of esculetin in the treatment of UC, which may shed light on the mechanism and treatment of UC.
format Online
Article
Text
id pubmed-10637478
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-106374782023-11-15 Network pharmacology and molecular docking reveal potential mechanism of esculetin in the treatment of ulcerative colitis Cai, Ting Cai, Bin Medicine (Baltimore) 3800 Ulcerative colitis (UC) is a chronic inflammatory bowel disease of the colonic mucosa. Esculetin is a type of natural coumarin that has many pharmacological activities such as antioxidant, anticancer, anti-inflammatory, etc. A previous study showed that esculetin improved intestinal inflammation and reduced serum proinflammatory cytokines in UC. The present study aimed to utilize network pharmacology and molecular docking to explore the potential mechanism of esculetin against UC. The potential gene targets of esculetin were predicted through SwissTargetPrediction and Super-PRED web servers. UC-related genes were obtained from DisGeNet, OMIM, and GeneCards databases. The overlap between gene targets of esculetin and UC-related genes were identified as the potential targets of esculetin against UC. The interaction between these overlapping genes was analyzed by the STRING database and the core genes were identified by Cytoscape platform. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis of the core genes were then performed. And the results of these analyses were further confirmed through molecular docking. A total of 50 overlapping genes were identified as the potential action targets of esculetin against UC. Among them, 10 genes (AKT1, STAT1, CCND1, SRC, PTGS2, EGFR, NFKB1, ESR1, MMP9, SERPINE1) were finally identified as the core genes. The Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis results showed that the top signaling pathway associated with the core genes of esculetin against UC was the prolactin (PRL) signaling pathway. Molecular docking results showed that esculetin has a strong binding affinity to the core genes, as well as PRL and prolactin receptor. This study suggests that esculetin may have a crucial impact on UC through the PRL signaling pathway and provides insights into the potential mechanism of esculetin in the treatment of UC, which may shed light on the mechanism and treatment of UC. Lippincott Williams & Wilkins 2023-11-10 /pmc/articles/PMC10637478/ /pubmed/37960728 http://dx.doi.org/10.1097/MD.0000000000035852 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle 3800
Cai, Ting
Cai, Bin
Network pharmacology and molecular docking reveal potential mechanism of esculetin in the treatment of ulcerative colitis
title Network pharmacology and molecular docking reveal potential mechanism of esculetin in the treatment of ulcerative colitis
title_full Network pharmacology and molecular docking reveal potential mechanism of esculetin in the treatment of ulcerative colitis
title_fullStr Network pharmacology and molecular docking reveal potential mechanism of esculetin in the treatment of ulcerative colitis
title_full_unstemmed Network pharmacology and molecular docking reveal potential mechanism of esculetin in the treatment of ulcerative colitis
title_short Network pharmacology and molecular docking reveal potential mechanism of esculetin in the treatment of ulcerative colitis
title_sort network pharmacology and molecular docking reveal potential mechanism of esculetin in the treatment of ulcerative colitis
topic 3800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637478/
https://www.ncbi.nlm.nih.gov/pubmed/37960728
http://dx.doi.org/10.1097/MD.0000000000035852
work_keys_str_mv AT caiting networkpharmacologyandmoleculardockingrevealpotentialmechanismofesculetininthetreatmentofulcerativecolitis
AT caibin networkpharmacologyandmoleculardockingrevealpotentialmechanismofesculetininthetreatmentofulcerativecolitis